512 related articles for article (PubMed ID: 31947673)
1. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
[TBL] [Abstract][Full Text] [Related]
2. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F
Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
5. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
Li XT; Li YS; Shi ZY; Guo XL
Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
[TBL] [Abstract][Full Text] [Related]
6. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
7. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.
Rasola A; Neckers L; Picard D
Trends Cell Biol; 2014 Aug; 24(8):455-63. PubMed ID: 24731398
[TBL] [Abstract][Full Text] [Related]
9. The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy.
Xie S; Wang X; Gan S; Tang X; Kang X; Zhu S
Front Oncol; 2020; 10():585047. PubMed ID: 33575209
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
Siegelin MD
Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
[TBL] [Abstract][Full Text] [Related]
12. TRAP1 Chaperones the Metabolic Switch in Cancer.
Wengert LA; Backe SJ; Bourboulia D; Mollapour M; Woodford MR
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740911
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance.
Falone S; Lisanti MP; Domenicotti C
Oxid Med Cell Longev; 2019; 2019():4647807. PubMed ID: 31915507
[No Abstract] [Full Text] [Related]
15. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
[TBL] [Abstract][Full Text] [Related]
16. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
17. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
[No Abstract] [Full Text] [Related]
18. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
Gallerne C; Prola A; Lemaire C
Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
Gentric G; Mieulet V; Mechta-Grigoriou F
Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
